Psychological treatment may reduce the need for healthcare in patients with Crohn's disease

被引:62
|
作者
Deter, Hans-Christian
Keller, Wolfram
von Wietersheim, Joern
Jantschek, Guenther
Duchmann, Rainer
Zeitz, Martin
机构
[1] Dept Psychosomat Med & Psychotherapy, D-12200 Berlin, Germany
[2] Med Univ Lubeck, Dept Psychosomat Med & Psychotherapy, Lubeck, Germany
[3] Med Clin Gastroenterol 1, Berlin, Germany
关键词
Crohn's disease; health care utilization; outcome study; psychological intervention;
D O I
10.1002/ibd.20068
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Few published studies examine the influence of psychological treatment on health care utilization in Crohn's disease. Methods: The present substudy of a prospective, randomized, multicenter trial conducted in 69 of 488 consecutive Crohn's disease (CD) patients was designed to investigate the way in which healthcare utilization is influenced by psychotherapy and relaxation in addition to standardized glucocorticoid therapy. Before and after a I-year period of standardized somatic treatment the psychotherapy and control groups were compared with regard to hospital and sick-leave days. Predictors of healthcare utilization were analyzed. Results: The comparison between groups before and after psychological treatment showed a significantly higher decrease of mean hospital days (P < 0.03) and sick-leave days in the treatment group compared with the controls. When a covariate analysis was applied to compare the data at randomization, the difference in hospital days remained statistically a trend (P < 0.1). Multivariate regression analysis detected a significant gender and depression effect for hospital days (cor r(2) = 0.114) and a significant gender and age effect for sick-leave days (cor r(2) = 0.112). Conclusion: A significant drop in healthcare utilization after psychological treatment demonstrates a clear benefit of this additional therapy. This is important, since the study failed to demonstrate significant changes in the psychosocial status or somatic course of study patients. Clinical and psychological factors influencing these outcomes are discussed.
引用
收藏
页码:745 / 752
页数:8
相关论文
共 50 条
  • [21] HEALTHCARE SERVICE UTILIZATION AND COSTS OF CERTOLIZUMAB PEGOL VERSUS INFLIXIMAB TREATMENT IN PATIENTS WITH CROHN'S DISEASE
    Tkacz, Joseph
    Lee, Edward
    Low, Robert
    Stark, Jeffrey
    Yassine, Mohamed
    Brady, Brenna L.
    GASTROENTEROLOGY, 2018, 154 (01) : S22 - S22
  • [22] Healthcare Providers Underestimate Patients' Glucocorticoid Use in Crohn's Disease
    Ghosh, Subrata
    Bressler, Brian
    Petkau, Jill
    Thakkar, Roopal B.
    Wang, Song
    Skup, Martha
    Chao, Jingdong
    Panaccione, Remo
    Schreiber, Stefan
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (05) : 1142 - 1149
  • [23] Healthcare Providers Underestimate Patients’ Glucocorticoid Use in Crohn’s Disease
    Subrata Ghosh
    Brian Bressler
    Jill Petkau
    Roopal B. Thakkar
    Song Wang
    Martha Skup
    Jingdong Chao
    Remo Panaccione
    Stefan Schreiber
    Digestive Diseases and Sciences, 2019, 64 : 1142 - 1149
  • [24] Early treatment with infliximab for Crohn's disease patients
    de Chambrun, G. Pineton
    Libier, L.
    Nachury, M.
    Collins, M.
    Koriche, D.
    Gower-Rousseau, C.
    Zerbib, P.
    Cortot, A.
    Colombel, J. -F.
    Desreumaux, P.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S251 - S252
  • [25] Adalimumab for the Treatment of Fistulas in Patients with Crohn's Disease
    Fine, Steven N.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (02) : 667 - 668
  • [26] Treatment of the anastomotic complications in patients with Crohn's disease
    Iesalnieks, Igors
    Kilger, Alexandra
    Kalisch, Barbara
    Obermeier, Florian
    Schlitt, Hans J.
    Agha, Ayman
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2011, 26 (02) : 239 - 244
  • [27] Adalimumab for the treatment of fistulas in patients with Crohn's disease
    Colombel, J-F
    Schwartz, D. A.
    Sandborn, W. J.
    Kamm, M. A.
    D'Haens, G.
    Rutgeerts, P.
    Enns, R.
    Panaccione, R.
    Schreiber, S.
    Li, J.
    Kent, J. D.
    Lomax, K. G.
    Pollack, P. F.
    GUT, 2009, 58 (07) : 940 - 948
  • [28] Early Treatment With Infliximab for Crohn's Disease Patients
    de Chambrun, Guillaume Pineton
    Libier, Louise
    Nachury, Maria
    Collins, Michael
    Koriche, Dine
    Gower-Rousseau, Corinne
    Zerbib, Philippe
    Cortot, Antoine
    Colombel, Jean-Frederic
    Desreumaux, Pierre
    GASTROENTEROLOGY, 2015, 148 (04) : S864 - S864
  • [29] Infliximab for the treatment of fistulas in patients with Crohn's disease
    Present, DH
    Rutgeerts, P
    Targan, S
    Hanauer, SB
    Mayer, L
    van Hogezand, RA
    Podolsky, DK
    Sands, BE
    Braakman, T
    DeWoody, KL
    Schaible, TF
    van Deventer, SJH
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (18): : 1398 - 1405
  • [30] Treatment of the anastomotic complications in patients with Crohn's disease
    Igors Iesalnieks
    Alexandra Kilger
    Barbara Kalisch
    Florian Obermeier
    Hans J. Schlitt
    Ayman Agha
    International Journal of Colorectal Disease, 2011, 26 : 239 - 244